INTRODUCTION:
Positron emission tomography (PET) is a functional imaging modality using FDG which is the most commonly used radiotracer in oncology imaging. FDG is an analogue of glucose and its uptake is 
Pitfalls PET/CT is classified into:
1) Normal distribution and physiological variants of 18 F-FDG uptake:
The normal distribution and physiologic variants of 18 F-FDG uptake is important to be recognized so as to avoid misinterpretation (6, 7) .
1.1) Brain:
The normal brain is characterized by a high level of 18 F-FDG uptake. Up to 6% of an administered dose of 18 F-FDG may be taken up in the brain as glucose provides approximately 95% of the energy used by the brain ( .
1.3) Thyroid gland:
Usually shows diffuse symmetric uptake, however, such diffuse thyroid uptake may represent Graves' disease or thyroiditis.
Focal thyroid uptake can be seen in benign thyroid nodules or malignancies, and further work-up is warranted in such cases (8, 10)
.
1.4) Thymus:
Diffuse and homogeneous uptake in the thymus is common in healthy children. The uptake is bi-lobed with an inverted V shape on coronal views.
Generally, physiologic uptake in the thymus disappears during adolescence in conjunction with involution of the thymus.
Thymic hyperplasia (or -rebound‖) is seen following chemotherapy more often in young adults. Very intense uptake or In patients with known malignancy, physiologic uptake of FDG by the hyperplastic thymus is more prevalent than previously thought, and it can be seen within the normal thymus as well.
Therefore, it is important to correlate any FDG avidity of thymic tissue with morphologic and attenuation findings on CT (16) . Following chemotherapy, FDG uptake can be seen in the thymus of 75% of children and in 5% to 16% of adults and enlargement can persist for up to six months following completion of chemotherapy.
In general, physiologic uptake of FDG in the thymus disappears in adolescence in conjunction with involution of the thymus.
Rebound thymic hyperplasia is seen in young patients treated for malignancy.
Normal thymic activity will appear triangular or -V‖ shaped (bilobed) and will usually have low to moderate uptake. Lack They did not find a superior thymic extension in any of subjects (19) .
1.5) Cardiac:
Activity is variable, ranging from no Esophageal activity can be noted as mild linear uptake anterior to the spine and is best seen in the sagittal plane. Most commonly this is seen in oncology patients, and esophageal uptake represents post-treatment mucositis related to either chemotherapy or radiation (13) .
Gastric curvilinear homogeneous uptake corresponding to the gastric wall is commonly identified. If the stomach is contracted, a round area of moderate activity may be seen.
Gastric uptake is usually mild, but more intense uptake may be associated with Helicobacter pylori infection. 
1.10) Muscular system:
Physiologic muscle uptake is commonly encountered at 18 F-FDG studies due to excessive muscle activity during the uptake phase reflecting the involved muscles.
High muscle uptake is most commonly seen in the head, neck, and thorax and less commonly in the lower extremities.
The pattern is usually distinctive and symmetric in various muscle groups.
However, asymmetric muscle uptake can occur. Marked uptake can be seen after excessive exercise or muscle tension. The chewing of gum after 18 F-FDG injection can cause symmetric intense uptake in the masseter muscles.
The intercostal muscles and accessory muscles of respiration can be detected in .
2.2) Metallic objects:
Prostheses, pacemakers, or chemotherapy catheters can cause virtuously increased activity and lead to false-positive results. Viewing the non-attenuation-corrected PET images can help distinguish this attenuation correction artifact from true hypermetabolism, since this virtuous high activity will not be present on the noncorrected images (32, 33) .
The high CT attenuation values (in

2.3) Respiratory motion:
Respiratory motion can cause misregistration of PET and CT scans, leading to attenuation correction artifact.
The liver dome and spleen may be seen Looking into the future, the most ideal solution to manage respiratory motion is to acquire data in list mode, use a data-driven self-gating technique to gate the PET activities into multiple bins over a respiratory cycle (37) .
2.4) Truncation artifacts:
The completely included. This cannot be applied in head and neck region; instead it can be replaced for by separate PET position.
3) Benign causes of abnormal 18 F-FDG uptake:
3.1) Benign bone lesions:
Non-ossifying fibromas and fibrous cortical defects are typically located in the metaphysis or diametaphyseal junction of the distal femur or proximal tibia. Such lesions manifest with variably, often intensely, increased 18 F-FDG uptake and may mimic malignant bone disease.
Correlation with CT findings from a PET/CT study can help in characterizing these lesions and will show an eccentric low-attenuation lesion with a thin sclerotic rim (40) .
3.2) Infection and Inflammation:
Focal (38) .
4.2) Drug Toxicity:
Drug toxicity of the lung is not uncommon during or after chemotherapy. Bleomycin is one of the most commonly used drugs for the treatment of Hodgkin disease, with up to 5% of patients to whom it is administered developing pulmonary drug toxicity. Diffuse increased FDG accumulation in the lungs has been reported with this condition (40) .
4.3) Granulocyte-Colony Stimulating
Factor Therapy:
G-CSF is a glycoprotein hormone that primarily regulates proliferation and differentiation of granulocyte precursors.
G-CSF has been used increasingly to correct chemotherapy-induced neutropenia and has reduced infections. Increased FDG uptake is often observed in bone marrow and spleen during and after G-CSF therapy. bone (42, 43) .
4.5) Post-operative Changes:
Healing involves an inflammatory reaction even in the absence of infection. 
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